NCT03139292View on ClinicalTrials.gov

Comparative Evaluation of Ambu AuraGain Laryngeal Mask and Proseal Laryngeal Mask Airway

NACompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

October 31, 2019

Study Completion Date

October 31, 2019

Conditions
Laryngeal Masks
Interventions
DEVICE

ProSeal Laryngeal Mask Airway

ProSeal Laryngeal Mask Airway was used as the supraglottic device

DEVICE

AmbuAuraGain Laryngeal Mask Airway

AmbuAuraGain Laryngeal Mask Airway was used as the supraglottic device

Trial Locations (1)

831001

Tata Main Hospital, Jamshedpur

All Listed Sponsors
lead

Tata Main Hospital

OTHER

NCT03139292 - Comparative Evaluation of Ambu AuraGain Laryngeal Mask and Proseal Laryngeal Mask Airway | Biotech Hunter | Biotech Hunter